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Speciﬁc immunoglobulin E (IgE) responses are upregulated
during chronic schistosome infection and during allergy.
These responses are tightly regulated during schistosomia-
sis. We have previously shown that IgE regulation depends
on the extent and length of exposure to individual parasite
allergen-like proteins. Here we compare the development of
IgE and immunoglobulin G4 (IgG4) responses to the differ-
entially expressed allergen-like proteins SmTAL1 and
SmTAL2 among preschool-aged children from 2 villages
with different levels of Schistosoma mansoni transmission.
We found a lack of SmTAL1 responsiveness among all chil-
dren, but evidence for IgG4-dependent IgE-SmTAL2 desen-
sitization in both villages, occurring earlier among children
from the village where the level of transmission was greater.
Findings provide insights into the development and regula-
tion of allergic-type immune responses.
Keywords. IgE; IgG4; schistosomiasis; Schistosoma
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Evidence is accumulating that preschool-aged children (PSAC)
are at signiﬁcant risk of schistosomiasis [1]. However, relative-
ly little is known about the immunoepidemiology of Schistoso-
ma species infection among these children and, hence, about
the early development and regulation of the immune response
to schistosomiasis in populations where Schistosoma species
are endemic. Among older children and adults, chronic infec-
tion is associated with a skewed type 2 response, with elevated
levels of speciﬁc immunoglobulin E (IgE) and eosinophilia [2];
these responses are also typical of allergy. In allergy, speciﬁc
IgE induces a potentially lethal inﬂammatory response. A sim-
ilar IgE response directed at antigen from relatively short-lived
eggs that are trapped in host tissues everyday during schisto-
some infection [3] would be disastrous for both host and para-
site. Instead, both have coevolved to produce/induce a tightly
regulated immune response during infection, mediated by
factors such as interleukin 10 and T-regulatory cells (Tregs),
as well as immunoglobulin G4 (IgG4), which is capable of
blocking IgE-allergen interaction [2].
We have shown previously that IgE regulation depends on
the extent and length of exposure to individual parasite allergen-
like proteins ( Jones et al, unpublished data). IgE responses to
SmTAL2, a member of the tegumental allergen-like (TAL)
family expressed throughout the parasite’s life cycle, including
the egg stage [4], were low among long-term residents of a
Schistosoma mansoni–endemic area of Kenya but signiﬁcantly
higher among recent immigrants to the same area. In contrast,
SmTAL2-IgG4 responses were higher among residents;
removal of IgG from sera resulted in signiﬁcantly higher
SmTAL2-IgE levels among residents, to the extent that levels
were higher than those detected in immigrants. This demon-
strates IgG-dependent desensitization of SmTAL2-IgE re-
sponses among individuals with long-term exposure.
SmTAL1 is another TAL protein but is principally expressed
in adult worms; anti-SmTAL1 IgE is associated with immunity
to infection [5, 6]. In the same study in Kenya, SmTAL1-IgE
and SmTAL1-IgG4 levels were both high among residents and
signiﬁcantly lower among immigrants ( Jones et al, unpub-
lished data). In communities of endemicity, SmTAL1-IgE and
SmTAL1-IgG4 responses increase with age and after chemo-
therapeutic drug treatment [4]. In the mouse, where schisto-
some worms outlive their host, SmTAL1-IgE responses only
develop following repeated rounds of infection and praziquan-
tel treatment, whereas SmTAL2-IgG and SmTAL2-IgE are
seen relatively early ( Jones et al, unpublished data). Taken to-
gether, this evidence suggests that SmTAL1 responses and
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associated immunity take much longer to develop after repeat-
ed exposure to dying worms.
In the current study, we investigate the development of IgE
and IgG4 responses to SmTAL1 and SmTAL2 in PSAC. The
study was conducted in 2 separate villages with different
degrees of transmission. We compare age-related changes in
IgE and IgG4 responses to SmTAL1 and SmTAL2, to deter-
mine how the extent of exposure determines the early develop-
ment and regulation of these allergic-type responses. Previous
ﬁndings would predict that few PSAC have anti-TAL1 re-
sponses, but that they might have greater, un-regulated, and
potentially damaging, IgE-SmTAL2 levels. This combination
of responses could result in increased susceptibility to infec-
tion and morbidity, highlighting the potential beneﬁts of in-
cluding PSAC in schistosomiasis control programs.
METHODS
This study forms part of a larger Schistosomiasis in Mothers
and Infants (SIMI) project which was conducted in 6
S. mansoni–endemic communities in Uganda and described in
detail elsewhere [7]. The London School of Hygiene and Topical
Medicine and the Ugandan National Council of Science and
Technology granted ethics approval. Brieﬂy, mothers and up to
2 of their children (age, 0.5–5 years) were recruited, and written
informed consent obtained on behalf of children. Stool samples
were obtained from each child on 2 consecutive days, and two
41.7 mg Kato-Katz thick slides [8] were prepared from each
specimen; 75-µL blood samples were obtained by ﬁnger prick.
Mothers were interviewed in the local language about their
knowledge of schistosomiasis, their demographic characteristics,
and both their and their children’s water contact behavior and
history of schistosomiasis treatment. The current study draws on
baseline data and sera collected in April 2009 from 426 children
of 213 mothers living in the villages of Bugoigo and Piida,
Bulissa District, Lake Albert.
SmTAL1 (Sm22.6; XP_002575844) and SmTAL2 (Sm21.7;
XP_002569898) were prepared as previously described [5].
Serum from blood samples obtained by ﬁnger prick was
stored at −80°C until required. Levels of IgE and IgG4 to
SmTAL1 and SmTAL2 were measured using biotinylated
isotype-speciﬁc monoclonal antibodies, as described elsewhere
[4]. Sample sera and plasma from noninfected European con-
trols were assayed in duplicate at concentrations of 1:20 (IgE) and
1:200 (IgG4). A 3-fold serial dilution of puriﬁed human IgG4
(Sigma-Aldrich, United States) or IgE myeloma (Calbiochem,
Germany) was added to each plate, forming a 14-point stan-
dard curve, starting at 30 µg/mL. Plates were read at dual
wavelengths (490 and 630 nm) on a Powerwave HT microplate
reader (BioTek Instruments). Results were interpolated from
standard curves with a 5 parameter curve ﬁt, using Gen5 anal-
ysis software (BioTek Instruments).
For analysis, infection intensity was expressed as mean egg
count per gram (epg); geometric means were calculated to
allow for skewness of data. Detection thresholds for enzyme-
linked immunosorbent assay readings for each antigen and
isotype were calculated as the mean plus 3 SDs of noninfected
European control plasma samples. Risk factors for infection
were examined using forward-ﬁtting 2-level logistic regression
analysis, to allow for correlations between siblings. Sex-
adjusted associations between seroprevalence, age, and village
were similarly examined using 2-level logistic models; age-
village interactions were tested to determine whether associa-
tions varied with age and village. Nonlinear associations were
examined by testing quadratic terms and categorical variables.
Multilevel models were ﬁtted in MLwiN (Bristol University,
United Kingdom); other analyses were conducted using Stata,
version 10.1 (StataCorp, United States).
RESULTS
Overall, 42.1% of children had detectable S. mansoni, and the
geometric mean infection intensity among those infected was
49.23 epg. The prevalence and intensity of infection varied sig-
niﬁcantly by village. In Bugoigo, the prevalence was 53.0%,
compared with 27.5% in Piida (P < .001), and geometric mean
intensity of infection among infected individuals was 61.38
epg in Bugoigo and 27.79 epg in Piida (P = .002).
The prevalence of key demographic and behavioral risk
factors, determined by the questionnaire, is presented in
Table 1 by village; also displayed are associations between risk
factors and infection. The likelihood of infection was increased
among certain ethnic groups, with age, with the duration of
water contact, and on learning to swim (P≤ .03). Children
from Bugoigo were more likely to be of “other” ethnic groups
(which was associated with a greater odds of infection), to
spend more time in the water, and to be brought to the water
by their mother, compared with children from Piida (Table 1);
these behavioral differences help explain the higher prevalence
of infection among Bugoigo children, although environmental
factors are also likely to be important.
To investigate how the degree of exposure inﬂuences the
early development of immune responses to S. mansoni, we
measured children’s anti-SmTAL1 and anti-SmTAL2 IgE and
IgG4 responses. Virtually none of the 301 children who
donated serum produced SmTAL1-IgE or IgG4 responses:
SmTAL1-IgE and SmTAL1-IgG4 were detected in 1 child (age,
4 years) and in 2 children (mean age, 4 years; both were
treated previously), respectively, at very low levels. In contrast,
72 (23.9%) children had detectable SmTAL2-IgE, and 180
(59.8%) children had detectable SmTAL2-IgG4. Although
there was no signiﬁcant difference in the prevalence of
SmTAL2-IgE responsiveness among infected versus noninfect-
ed children (prevalence, 25.9% among infected children and
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22.4% among noninfected children; P = .65 after adjustment for
age and sex), the prevalence of SmTAL2-IgG4 responsiveness
was signiﬁcantly greater among infected children (prevalence,
72.6% vs 48.4%; P = .01 after adjustment for age and sex). The
prevalence of both responses varied by village and with age; for
anti-SmTAL2-IgE, associations with age varied signiﬁcantly by
village (age-village interaction, P = .001). Overall, 13.9% of chil-
dren from Bugoigo had detectable SmTAL2-IgE responses,
compared with 38.8% of children from Piida (P < .001 after ad-
justment for age and sex). Figure 1A displays the predicted
probability of SmTAL2-IgE responsiveness over age, by village.
Among infants from Piida, the predicted anti-SmTAL2-IgE
prevalence initially increased rapidly with age but peaked and
then declined at around 4 years of age. Among infants from
Bugoigo, in contrast, the predicted probability was overall lower
and decreased with age.
Figure 1B displays the predicted probability of an anti-
SmTAL2-IgG4 response over age, by village. Unlike the predicted
anti-SmTAL2-IgE prevalence, the predicted anti-SmTAL2-IgG4
prevalence increased linearly with age in both villages. Further-
more, the likelihood of a response was signiﬁcantly greater
among children from Bugoigo, compared with children from
Piida (P < .0001 after adjustment for age and sex), with 89.4% of
children from Bugoigo having a detectable SmTAL2-IgG4 re-
sponse, compared with only 15.7% of children from Piida.
DISCUSSION
SmTAL1 is a member of the TAL family, a family of proteins
differentially expressed throughout the schistosome life cycle
that share structural homology with the EF-hand allergens, one
of the most common group of clinical allergens [4]. It is
Table 1. Distribution of Risk Factors and Association Between Risk Factors and Schistosoma mansoni Infection Among Preschool-
Aged Children (PSAC)
Distributiona Association With Infection
Risk Factor Bugoigo Piida P PSAC Infected, % Adjustedb OR (95% CI) Pc
Village
Bugoigo … … 53.02 Reference
Piida … … 27.50 .20 (.09–.43) <.0001
Sex
Female 111 (51.15) 77 (47.83) 42.25 Reference
Male 106 (48.85) 84 (52.17) .52 41.71 1.15 (.60–2.20) .66
Age, y, mean 3.11 2.94 .26 1.37 (1.06–1.76) .02
Ethnic background
Banyoro 18 (6.87) 14 (8.75) 41.38 .93 (.23–3.77)
Bagungu 58 (22.14) 30 (18.75) 28.57 .31 (.12–.75)
Alur 150 (57.25) 110 (68.75) 43.67 Reference
Otherd 36 (13.74) 6 (3.75) .004 63.89 4.13 (1.03–16.62) .004
Water contact duration, h
Never 97 (45.12) 68 (42.77) 30.00 Reference
<0.5 42 (19.53) 53 (33.33) 39.36 .76 (.25–2.29)
0.5–1 27 (12.56) 21 (13.21) 55.32 3.06 (.90–10.45)
>1 to 2 43 (20.00) 14 (8.81) 63.16 6.20 (1.71–22.50)
>2 6 (2.79) 3 (1.89) .01 77.78 6.78 (.34–134.69) .01
Can swim
No 185 (87.68) 111 (71.15) 39.45 Reference
Yes 26 (12.32) 45 (28.85) <.001 53.52 3.26 (1.14–9.33) .03
Mother brings to water
No 124 (65.26) 122 (80.26) 39.26 Reference
Yes 66 (34.74) 30 (19.74) .002 50.00 .43 (.16–1.17) .10
Abbreviations: CI, confidence interval; OR, odds ratio.
a Data are no. (%) of PSAC, unless otherwise indicated.
b Estimated using forward-fitting 2-level logistic regression. The following variables were included and retained if significant at the P < .1 level: village, age, water
contact duration, child treated for schistosomiasis, child can swim, ethnic background, mother brings child to water, site where child is bathed (lake vs home),
frequency of bathing, mother’s occupation, and whether mother had heard of schistosomiasis (or Bilharzia). Infection was defined as ≥1 detectable S. mansoni
eggs in Kato-Katz slides.
c By likelihood ratio tests.
d Congolese and other minority ethnic groups.
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principally expressed in the adult worm and thought to be se-
questered from the immune system in live worms. In areas of
endemicity, responses to SmTAL1 steadily increase with age, it
is thought following gradual, accumulated exposure to antigen
released from dying worms [4]. SmTAL2, another TAL, is ex-
pressed throughout the parasite’s life cycle, including the egg
stage; hence, exposure is continuous during infection because of
the release of SmTAL2 from short-lived eggs trapped in tissue.
In contrast to SmTAL1-IgE, SmTAL2-IgE responses are low
among long-term exposed individuals but signiﬁcantly higher
among recently exposed individuals; there is strong evidence to
suggest that this is due to IgG4-dependent SmTAL2-IgE desensi-
tization ( Jones et al, unpublished data).
In the current study, we examined SmTAL1- and SmTAL2-
IgE and IgG4 responses among PSAC from an S. mansoni–
endemic region of Uganda. On the basis of ﬁndings from pre-
vious studies, we hypothesized that children would have no or
low anti-TAL1 responses but higher, unregulated TAL2-IgE
responses. The children studied were from 2 villages with dif-
ferent levels of transmission: children from Bugoigo had sig-
niﬁcantly greater risk of infection than children from Piida. In
Bugoigo, SmTAL2-IgE responses decreased with age and were
overall lower than in Piida, where responses increased then de-
creased with age. In contrast, the prevalence of SmTAL2-IgG4
responsiveness was higher in Bugoigo, and the likelihood of a
response increased with age in both villages. These ﬁndings are
consistent with previous observations comparing SmTAL2 re-
sponses among resident and immigrant populations ( Jones
et al, unpublished data) and provide further support for our hy-
pothesis that SmTAL2-IgE is an early human immune response
to S. mansoni, which is downregulated during chronic infection,
probably because of IgG4-dependent desensitization. The rapid-
SmTAL2-IgE desensitization observed in Bugoigo highlights the
acute nature of this response. Since the average lifespan of S.
mansoni adult worms is 7 years [9], the observed lack of SmTAL1
responsiveness among PSAC is entirely expected and conﬁrms
that this is a much later response that develops after repeated
exposure to antigen following natural or induced worm death.
Chronic schistosomiasis morbidity is caused by T-helper 2
granulomatous responses to continuous deposition of eggs,
which over years [10] can cause severe ﬁbrotic disease [11].
Acute schistosomiasis is also thought to be a reaction pro-
voked by eggs, as well as by migrating schistosomulae [12].
IgE-mediated inﬂammation, triggered by egg allergen-like an-
tigens such as SmTAL2, could play a role in this and could
also occur in very young children in schistosomiasis-endemic
areas. If so, SmTAL2-IgE modulation would limit IgE-mediated
tissue damage, similarly to allergen-speciﬁc immunotherapy
(SIT), in which repeated allergen administration is used to
induce IgE desensitization. Immunological changes associated
with SIT include reductions in IgE, induction of Tregs, and
increases in allergen-speciﬁc IgG, particularly IgG4 [13]. IgG is
thought to directly compete for the same epitopes as IgE,
downmodulating both IgE-dependent histamine release [14]
and IgE-facilitated allergen presentation to T cells [15].
Figure 1. Predicted probability for TAL2 immunoglobulin E (A) and
TAL2 immunoglobulin G4 (B) responsiveness among infants in Bugoigo
(dashed line) and Piida (solid line). A total of 180 children in Bugoigo
(68.7%) donated sera, 98 (56.0%) of whom had detectable infection. A
total of 121 children in Piida (73.8%) donated sera, 37 (30.6%) of whom
had detectable infection. A, A statistically signiﬁcant age-village interac-
tion was observed (χ2 [3 df ] = 16.01; P = .001); age was modeled as a
categorical variable because of departure from linearity for Piida esti-
mates (P = .01). Model-predicted odds ratios (ORs) were as follows: male
sex, 0.68 (95% conﬁdence interval [CI], .36–1.29); village (Piida), 0.77
(95% CI, .26–2.32); age 2.1–3 years, 0.82 (95% CI, .27–2.55); age 3.1–4
years, 0.52 (95% CI, .14–1.97); age 4.1–6 years, 0.41 (95% CI, .11–1.54);
age 2.1–3 years*Piida interaction term, 7.29 (95% CI, 1.33–40.05); 3.1–4
years*Piida interaction term, 25.36 (95% CI, 4.35–147.68); and age 4.1–6
years*Piida interaction term, 14.18 (95% CI, 2.43–82.76). B, No signiﬁ-
cant age-village interaction was observed (χ2 [3 df ] = 0.374; P = .541);
age was modeled as a continuous variable because there was no depar-
ture from linearity (P = .274). Model-predicted ORs were as follows: male
sex, 0.44 (95% CI, .20–.94); village (Piida), 0.01 (95% CI, .003–.02); and
age, 2.03 (95% CI, 1.54–2.67).
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In summary, the current study investigated the development
of IgE and IgG4 responses to the allergen-like proteins
SmTAL1 and SmTAL2 among PSAC from 2 separate villages
with different degrees of S. mansoni transmission. We provid-
ed evidence for IgG4-dependent IgE desensitization to consti-
tutively expressed SmTAL2; this desensitization occurred
earlier in the higher transmission village. Almost no children
had developed detectable responses to the worm antigen
SmTAL1, most likely because of a lack of sufﬁcient exposure
to antigen. Our results conﬁrm previous ﬁndings suggesting
that the degree of IgE regulation is dependent on the extent
and length of antigen exposure: we hypothesize that poten-
tially pathogenic IgE responses to continuously-released
SmTAL2 are tightly regulated among adults in regions of en-
demicity but that SmTAL1-IgE responses are less regulated,
because of only periodic exposure following worm death.
Findings will help our understanding of immune responses
in schistosomiasis and in allergy, providing insights for the
therapeutic treatment of both. A lack of immunity, combined
with higher prevalence of pathogenic IgE responses, could
increase the risk of severe morbidity among PSAC, highlight-
ing the beneﬁt for their inclusion in schistosomiasis control
programs.
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